Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2019–2026
- ALL3757726
- 239 Pages
- January 2020
- Healthcare
Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.
Increase in adoption of smartphones and tablets coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidence of chronic diseases drive the growth of the global digital therapeutics market. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 19.9% from 2019 to 2026. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future.
The global digital therapeutics market is segmented into application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product type, it is classified into software and devices. Further, on the basis of sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, business-to-business (B2B) is categorized into employers, healthcare providers, and others. By business-to-consumers, it is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2026, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
• By Application
o Diabetes
o Obesity
o Cardiovascular Disease (CVD)
o Central Nervous System (CNS) Disease
o Respiratory Disease
o Smoking Cessation
o Gastrointestinal Disorder (GID)
o Others
• By Product Type
o Software
o Device
• By Product Type
o Business-to-Business (B2B)
Employer
Healthcare Provider
Others
o Business-to-Consumer (B2C)
Patient
Caregiver
• By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
o Asia-Pacific
• Australia
• Japan
• India
• China
• South Korea
• Rest of Asia-Pacific
o LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• Rest of LAMEA
1.1. Report description
1.2. Key benefits for stakeholders
1.3. key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top player positioning, 2018
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in adoption of smartphones and tablets coupled with healthcare apps
3.4.1.2. Growth in need to control healthcare costs
3.4.1.3. Rise in incidence of chronic diseases
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries
3.4.2.2. Patient data privacy concerns
3.4.3. Opportunity
3.4.3.1. Emerging markets offer significant growth opportunities
CHAPTER 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Diabetes
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Obesity
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Cardiovascular diseases
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Central nervous system (CNS) diseases
4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Gastrointestinal disorder
4.6.1. Key market trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Respiratory diseases
4.7.1. Key market trends and growth opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Smoking cessation
4.8.1. Key market trends and growth opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Others
4.9.1. Key market trends and growth opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
CHAPTER 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Software
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Devices
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Business-to-business (B2B)
6.2.1. Market size and forecast, by type
6.2.2. Employer
6.2.2.1. Market size and forecast
6.2.3. Healthcare Providers
6.2.3.1. Market size and forecast
6.2.4. Others
6.2.4.1. Market size and forecast
6.2.5. Market size and forecast, by region
6.2.6. Market analysis, by country
6.3. Business-to-consumers
6.3.1. Market size and forecast, by type
6.3.2. Patients
6.3.2.1. Market size and forecast
6.3.3. Caregivers
6.3.3.1. Market size and forecast
6.3.4. Market size and forecast, by region
6.3.5. Market analysis, by country
CHAPTER 7: DIGITAL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America digital therapeutics market, by country
7.2.2.1. U.S. digital therapeutics market, by application
7.2.2.2. U.S digital therapeutics market, by product type
7.2.2.3. U.S. digital therapeutics market, by sales channel
7.2.2.4. Canada digital therapeutics market, by application
7.2.2.5. Canada digital therapeutics market, by product type
7.2.2.6. Canada digital therapeutics market, by sales channel
7.2.2.7. Mexico digital therapeutics market, by application
7.2.2.8. Mexico digital therapeutics market, by product type
7.2.2.9. Mexico digital therapeutics market, by sales channel
7.2.3. North America digital therapeutics market, by application
7.2.4. North America digital therapeutics market, by product type
7.2.5. North America digital therapeutics market, by sales channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe digital therapeutics market, by country
7.3.2.1. UK digital therapeutics market, by application
7.3.2.2. UK digital therapeutics market, by product type
7.3.2.3. UK digital therapeutics market, by sales channel
7.3.2.4. Germany digital therapeutics market, by application
7.3.2.5. Germany digital therapeutics market, by product type
7.3.2.6. Germany digital therapeutics market, by sales channel
7.3.2.7. France digital therapeutics market, by application
7.3.2.8. France digital therapeutics market, by product type
7.3.2.9. France digital therapeutics market, by sales channel
7.3.2.10. Italy digital therapeutics market, by application
7.3.2.11. Italy digital therapeutics market, by product type
7.3.2.12. Italy digital therapeutics market, by sales channel
7.3.2.13. Spain digital therapeutics market, by application
7.3.2.14. Spain digital therapeutics market, by product type
7.3.2.15. Spain digital therapeutics market, by sales channel
7.3.2.16. Rest of Europe digital therapeutics market, by application
7.3.2.17. Rest of Europe digital therapeutics market, by product type
7.3.2.18. Rest of Europe digital therapeutics market, by sales channel
7.3.3. Europe digital therapeutics market, by application
7.3.4. Europe digital therapeutics market, by product type
7.3.5. Europe digital therapeutics market, by sales channel
7.4. Asia-pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific digital therapeutics market, by country
7.4.2.1. Japan digital therapeutics market, by application
7.4.2.2. Japan digital therapeutics market, by product type
7.4.2.3. Japan digital therapeutics market, by sales channel
7.4.2.4. China digital therapeutics market, by application
7.4.2.5. China digital therapeutics market, by product type
7.4.2.6. China digital therapeutics market, by sales channel
7.4.2.7. Australia digital therapeutics market, by application
7.4.2.8. Australia digital therapeutics market, by product type
7.4.2.9. Australia digital therapeutics market, by sales channel
7.4.2.10. India digital therapeutics market, by application
7.4.2.11. India digital therapeutics market, by product type
7.4.2.12. India digital therapeutics market, by sales channel
7.4.2.13. South Korea digital therapeutics market, by application
7.4.2.14. South Korea digital therapeutics market, by product type
7.4.2.15. South Korea digital therapeutics market, by sales channel
7.4.2.16. Rest of Asia-Pacific digital therapeutics market, by application
7.4.2.17. Rest of Asia-Pacific digital therapeutics market, by product type
7.4.2.18. Rest of Asia-Pacific digital therapeutics market, by sales channel
7.4.3. Asia-Pacific digital therapeutics market, by application
7.4.4. Asia-Pacific digital therapeutics market, by product type
7.4.5. Asia-Pacific digital therapeutics market, by sales channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA digital therapeutics market, by country
7.5.2.1. Brazil digital therapeutics market, by application
7.5.2.2. Brazil digital therapeutics market, by product type
7.5.2.3. Brazil digital therapeutics market, by sales channel
7.5.2.4. Turkey digital therapeutics market, by application
7.5.2.5. Turkey digital therapeutics market, by product type
7.5.2.6. Turkey digital therapeutics market, by sales channel
7.5.2.7. Saudi Arabia digital therapeutics market, by application
7.5.2.8. Saudi Arabia digital therapeutics market, by product type
7.5.2.9. Saudi Arabia digital therapeutics market, by sales channel
7.5.2.10. South Africa digital therapeutics market, by application
7.5.2.11. South Africa digital therapeutics market, by product type
7.5.2.12. South Africa digital therapeutics market, by sales channel
7.5.2.13. Rest of LAMEA digital therapeutics market, by application
7.5.2.14. Rest of LAMEA digital therapeutics market, by product type
7.5.2.15. Rest of LAMEA digital therapeutics market, by sales channel
7.5.3. LAMEA digital therapeutics market, by application
7.5.4. LAMEA digital therapeutics market, by product type
7.5.5. LAMEA digital therapeutics market, by sales channel
CHAPTER 8: COMPANY PROFILES
8.1. 2MORROW, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. FITBIT, INC. (TWINE HEALTH, INC.)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. LIVONGO HEALTH, INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Key strategic moves and developments
8.4. MEDTRONIC PLC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. OMADA HEALTH, INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Key strategic moves and developments
8.6. PEAR THERAPEUTICS, INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.6.4. Key strategic moves and developments
8.7. PROTEUS DIGITAL HEALTH, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. RESMED, INC. (PROPELLER HEALTH)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. VOLUNTIS, INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. WELLDOC, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
TABLE 01. GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 02. DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2018–2026 ($MILLION)
TABLE 03. DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2018–2026 ($MILLION)
TABLE 04. DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2026 ($MILLION)
TABLE 05. DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 2018–2026 ($MILLION)
TABLE 06. SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 07. DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 2018–2026 ($MILLION)
TABLE 08. DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2026 ($MILLION)
TABLE 09. DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2018–2026 ($MILLION)
TABLE 10. DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 12. DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS
TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 2018–2026 ($MILLION)
TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 2018–2026 ($MILLION)
TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 16. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 2018–2026 ($MILLION)
TABLE 17. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 2018–2026 ($MILLION)
TABLE 18. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 2018–2026 ($MILLION)
TABLE 19. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 2018–2026 ($MILLION)
TABLE 20. DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 21. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 22. U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 23. U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 24. U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 25. CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 26. CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 28. MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 33. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 34. EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 36. UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 37. UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 38. GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39. GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 40. GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 41. FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 42. FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 43. FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 44. ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 45. ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 46. ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 47. SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 48. SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 49. SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 50. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 51. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 52. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 53. EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 55. EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 56. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 57. JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 58. JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 59. JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 60. CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 61. CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 62. CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 63. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 64. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 65. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 66. INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 67. INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 68. INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 69. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 70. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 71. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 75. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 76. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 77. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 78. LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 79. BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 80. BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 81. BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 82. TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 83. TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 84. TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 85. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 86. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 87. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 88. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 89. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 90. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 91. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 92. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 93. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 94. LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 95. LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 96. LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 97. 2MORROW: COMPANY SNAPSHOT
TABLE 98. WELLDOC: PRODUCT PORTFOLIO
TABLE 99. FITBIT: COMPANY SNAPSHOT
TABLE 100. FITBIT: PRODUCT PORTFOLIO
TABLE 101. LIVONGO: COMPANY SNAPSHOT
TABLE 102. LIVONGO: PRODUCT PORTFOLIO
TABLE 103. MEDTRONIC: COMPANY SNAPSHOT
TABLE 104. MEDTRONIC: OPERATING SEGMENTS
TABLE 105. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 106. OMADA: COMPANY SNAPSHOT
TABLE 107. PEAR: COMPANY SNAPSHOT
TABLE 108. PEAR: PRODUCT PORTFOLIO
TABLE 109. PROTEUS: COMPANY SNAPSHOT
TABLE 110. PROTEUS: PRODUCT PORTFOLIO
TABLE 111. RESMED: COMPANY SNAPSHOT
TABLE 112. RESMED: OPERATING SEGMENTS
TABLE 113. RESMED: PRODUCT PORTFOLIO
TABLE 114. VOLUNTIS: COMPANY SNAPSHOT
TABLE 115. VOLUNTIS: OPERATING SEGMENTS
TABLE 116. VOLUNTIS: PRODUCT PORTFOLIO
TABLE 117. WELLDOC: COMPANY SNAPSHOT
TABLE 118. WELLDOC: PRODUCT PORTFOLIO
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
